Real-World Evidence for Real-Life Solutions: CCRAN and Signal49 Research Launch Phase II of Path-Defining Comprehensive Genomic Profiling Initiative
The Colorectal Cancer Resource & Action Network (CCRAN) today announced that Phase II of its genomic profiling research initiative is underway, continuing its collaboration with Signal49 Research (formerly The Conference Board of Canada). The new phase shifts the research focus from national economic modelling to real-world evidence, examining how genomic profiling is delivered, accessed, and used across Canada's cancer care systems. The Phase II findings are expected to be released early next y
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.